84-3552-50 [取扱停止]EIF2AK2, NT (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2, eIF-2A Protein Kinase 2, Interferon-induced, Double-stranded RNA-activated Protein Kinase, Interferon-inducible RNA-dependent pRotein Kinase, p68 kinase, Protein Kinase RNA-activated, PKR, P1/eIF-2A Protein Kinase, PRKR) (MaxLight 405) 100ul E8949-16-ML405

※お見積書はカートで印刷できます

冷蔵

特徴

  • MaxLight™ 405 is a new Violet photostable dye conjugate comparable to Alexa Fluor® 405, PacificBlue™, Brilliant™ Violet 421 and offers better labeling efficiency, brighter imaging and increased immunodetection.
  • Absorbance (400nm); Emission (423nm); Extinction Coefficient 32,000.
  • Interferon-induced, double-stranded RNA-activated protein kinase (PRKR) is a serine-threonine kinase.
  • Activation by dsRNAs leads to autophosphorylation of PRKR and allows the kinase to phosphorylate its natural substrate, the alpha subunit of eukaryotic protein synthesis initiation factor-2 (EIF2-alpha), leading to the inhibition of protein synthesis.
  • Human gamma-interferon (IFNG) mRNA exploits localized activation of PRKR in the cell to regulate its own translation.
  • IFNG mRNA activates PRKR through a pseudoknot in its 5-prime untranslated region.
  • The HCV envelope protein E2 contains a sequence identical with phosphorylation sites of the interferon-inducible protein kinase PRKR and the translation initiation factor EIF2-alpha, a target of PRKR.
  • E2 inhibits the kinase activity of PRKR and blocks its inhibitory effect on protein synthesis and cell growth, which provides one mechanism by which HCV may circumvent the antiviral effect of interferon.
  • PRKR, which is involved in TLR signaling and mediates apoptosis in fibroblasts in response to viral infection and inflammatory cytokines, also activates IKK and NFKB, thereby suppressing apoptosis.
  • Apoptosis induced by live pathogenic gram-positive and gram-negative bacteria requirs both TLR4 and PRKR, possibly representing a major mechanism for pathogenic bacteria that use specific virulence factors to avoid detection and destruction by the innate immune system.
  • Roles for PRKR activation in Huntington disease and Fanconi anemia have also been suggested.
  • Applications:Suitable for use in FLISA, Western Blot, and Immunohistochemistry.
  • Other applications not tested.
  • Recommended Dilution:FLISA: 1:1,000Western Blot: 1:100-1:500Immunohistochemistry: 1:50-1:100Optimal dilutions to be determined by the researcher.
  • Storage and Stability:Store product at 4°C in the dark.
  • DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid.
  • Dilute required amount only prior to immediate use.
  • Further dilutions can be made in assay buffer.
  • Caution: MaxLight™405 conjugates are sensitive to light.
  • For maximum recovery of product, centrifuge the original vial prior to removing the cap.
  • Note: Applications are based on unconjugated antibody.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Purified
  • Purity:Purified by ammonium sulfate precipitation.
  • Form:Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with MaxLight™405.
  • Specificity:Recognizes human PRKR. Species Crossreactivity: mouse.
  • Isotype:IgG
  • Calc Applications Abbrev:FLISA IHC WB
  • Calc Crossreactivity:Hu Mo
  • Immunogen:Synthetic peptide selected from the N-terminal region of human PRKR (KLH).
  • Shelf Life:1year
  • Swiss Prot Number:Q52M43
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-3552-50
型番
E8949-16-ML405
入り数
1個
標準価格
203,000円(税抜)
WEB価格
取扱停止
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る